@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com 5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com 6 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority